학술논문

The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study
Document Type
Article
Source
In: Journal of Crohn's and Colitis. (Journal of Crohn's and Colitis, 1 May 2024, 18(5):762-772)
Subject
Language
English
ISSN
18764479
18739946